Liebert, Debra Kay

Track

Insider profile

Performance

Overall performance
0.9
Performance over holding periods
0.9
30 days 90 days 120 days
Average return -10% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
7 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Liebert, Debra Kay's trades of Milestone Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
251.72
Quantity 3,904 -6.9%
Value US$2,319,758
Transaction date
Purchase
Price
71.53
Quantity 5,715 -23.2%
Value US$2,562,825
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2022-10-21 2022-10-21
B Purchase
63,354
85.55
US$3,438,104 		63,354 85.55 US$3,438,104
2022-10-21 2022-10-20
B Purchase
3,904 -6.9%
251.72
US$2,319,758 		3,904 -6.9% 251.72 US$2,319,758
2022-10-21 2022-10-20
B Purchase
5,715 -23.2%
71.53
US$2,562,825 		5,715 -23.2% 71.53 US$2,562,825
2022-10-21 2022-10-20
B Purchase
45 +0.5%
5.26
US$237 		45 +0.5% 5.26 US$237
2022-10-21 2022-10-20
B Purchase
2,655 +42.1%
5.28
US$14,018 		2,655 +42.1% 5.28 US$14,018
2022-10-21 2022-10-20
B Purchase
105 +1.7%
5.29
US$555 		105 +1.7% 5.29 US$555
2022-10-21 2022-10-20
B Purchase
6,195
5.30
US$32,834 		6,195 5.30 US$32,834